Results 121 to 130 of about 6,098 (220)

The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials

Medicina
Background and Objectives: Substance use disorders (SUDs) affect millions worldwide. Despite increasing drug use, treatment options remain limited.
Lavinia Hogea, Dana Cătălina Tabugan, Iuliana Costea, Oana Albai, Laura Nussbaum, Adriana Cojocaru, Leonardo Corsaro, Teodora Anghel   +7 more
doaj   +1 more source

Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating

Psychoactives
Accumulating psychedelic research has demonstrated a potential for improving mental health and wellbeing, yet studies in the context of eating disorders (EDs) are limited.
Nadine Loh, David Luke
doaj   +1 more source

Self-treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study

Kōtuitui
This study draws attention to, and provides a description of, a previously unmapped and emerging self-medication phenomenon occurring in Aotearoa New Zealand where psychedelic substances are being used in the absence of clinical supervision to address a ...
Chris Arnison, Richard Egan, John H. Shaver   +2 more
doaj   +1 more source

A conscious and sustainable therapeutic community for substance abuse [PDF]

, 2015
The current national situation regarding therapeutic centers for substance abuse is considered to be highly inefficient with little therapeutic impact on Ecuadorian society.
Flores Martínez, Sara Paola
core  

Equity in Altered States: Legal and Ethical Pathways to Inclusive Psychedelic-Assisted Therapy [PDF]

This thesis explores the lack of racial and ethnic diversity in psychedelic-assisted therapy clinical trials, identifying key barriers such as unfamiliarity with psychedelics and structural challenges like limited time off work.
Sepulveda, Rachel
core   +2 more sources

How do psychedelics impact people with a history of non-affective psychosis? A qualitative study

Frontiers in Psychiatry
BackgroundPeople with a history of psychotic disorders are excluded from contemporary trials of psychedelic-assisted therapy. Although survey studies have explored the impact of naturalistic psychedelic use on people with a history of psychotic disorders,
Haley Maria Dourron, Haley Maria Dourron, Heith Copes, Daniel H. Grossman, Melissa Bradley, Christopher R. Nicholas, Jessica A. Turner, Gaige Allen-Clark, Maggie Gossage, Peter S. Hendricks, Peter S. Hendricks   +10 more
doaj   +1 more source

Spartan Daily, March 4, 1983 [PDF]

, 1983
Volume 80, Issue 23https://scholarworks.sjsu.edu/spartandaily/7005/thumbnail ...
San Jose State University, School of Journalism and Mass Communications
core   +1 more source

The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting

Psychoactives
Czechia has recently approved the medical use of psilocybin, marking a pivotal shift in the country’s drug policy landscape. This development paves the way for regulated therapeutic applications of psilocybin within clinical settings, while ...
Tereza Dlestikova
doaj   +1 more source

Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States [PDF]

, 2023
Stacey B. Armstrong, Adam W. Levin, Yitong Xin, Jordan Horan, Jason B. Luoma, Paul Nagib, Brian Pilecki, Alan K. Davis   +7 more
openalex   +1 more source

Current perspectives on psychedelic treatments in Europe

The Lancet Regional Health. Europe
Summary: In this viewpoint, we explore the evolving landscape of psychedelic-assisted therapy in Europe, focusing on clinical, regulatory, and therapeutic developments.
Santiago Madero, Oscar Soto-Angona, Genis Ona, Jose Sanchez-Moreno, Eduard Vieta   +4 more
doaj   +1 more source